---
title: "Xolair (omalizumab), all indications: Indication questions"
description: "Indication questions on Xolair (omalizumab) that apply to every indication, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Drug names. Questions: What is the generic name of Xolair? What type of drug is Xolair (anti-IgE antibody)? 2 questions quoted from 1 source."
canonical: "https://www.evicenter.com/medical-information/xolair/indication"
published: "2026-11-14T01:54:55-05:00"
modified: "2026-11-14T15:19:23-05:00"
---

# Xolair (omalizumab), all indications: Indication questions

Manufacturer: Genentech, Inc.; Novartis Pharmaceuticals Corporation  
Prescribing information: [Xolair](https://www.gene.com/download/pdf/xolair_prescribing.pdf)  
Indication pages: [Allergic asthma](https://www.evicenter.com/medical-information/xolair--allergic-asthma)

## Drug names

<a id="xolair-generic-name"></a>

### What is the generic name of Xolair?

> “XOLAIR<sup>®</sup> (omalizumab) injection, for subcutaneous use 
> XOLAIR<sup>®</sup> (omalizumab) for injection, for subcutaneous use”

Source: [XOLAIR: Prescribing information, page 1, captured 2026-11-13](https://www.gene.com/download/pdf/xolair_prescribing.pdf#page=1)

<a id="xolair-drug-class"></a>

### What type of drug is Xolair (anti-IgE antibody)?

> “XOLAIR is an anti-IgE antibody indicated for:”

Source: [XOLAIR: Prescribing information, page 1, captured 2026-11-13](https://www.gene.com/download/pdf/xolair_prescribing.pdf#page=1)

> “Omalizumab is a recombinant DNA-derived humanized IgG1κ monoclonal antibody that 
> selectively binds to human immunoglobulin E (IgE).  The antibody has a molecular weight of 
> approximately 149 kiloDaltons.  XOLAIR is produced by a Chinese hamster ovary cell 
> suspension culture.”

Source: [XOLAIR: Prescribing information, page 26, captured 2026-11-13](https://www.gene.com/download/pdf/xolair_prescribing.pdf#page=26)

## Related pages
- [Medical information: Xolair (omalizumab): All indications](https://www.evicenter.com/medical-information/xolair)
- [Pharmacology](https://www.evicenter.com/medical-information/xolair/pharmacology)
- [Safety](https://www.evicenter.com/medical-information/xolair/safety)
- [Dosing and administration](https://www.evicenter.com/medical-information/xolair/dosing-and-administration)
- [Storage and supply](https://www.evicenter.com/medical-information/xolair/storage-and-supply)
- [Access and coverage](https://www.evicenter.com/medical-information/xolair/access-and-coverage)
